Taita Chemical Company, Limited
TWSE:1309.TW
18.25 (TWD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 15,205.462 | 18,083.799 | 20,771.165 | 15,498.381 | 17,672.204 | 21,683.702 | 19,821.042 | 16,419.055 | 17,028.115 | 20,933.816 | 21,438.961 | 18,633.595 | 18,433.06 | 18,454.462 | 14,120.695 |
| Cost of Revenue
| 14,780.682 | 16,323.674 | 17,385.209 | 12,375.109 | 16,426.138 | 20,639.959 | 18,387.338 | 15,473.799 | 16,155.834 | 20,855.152 | 20,930.084 | 17,998.095 | 17,592.819 | 17,185.906 | 12,957.597 |
| Gross Profit
| 424.78 | 1,760.125 | 3,385.956 | 3,123.272 | 1,246.066 | 1,043.743 | 1,433.704 | 945.256 | 872.281 | 78.664 | 508.877 | 635.5 | 840.241 | 1,268.556 | 1,163.098 |
| Gross Profit Ratio
| 0.028 | 0.097 | 0.163 | 0.202 | 0.071 | 0.048 | 0.072 | 0.058 | 0.051 | 0.004 | 0.024 | 0.034 | 0.046 | 0.069 | 0.082 |
| Reseach & Development Expenses
| 15.832 | 15.312 | 18.546 | 20.523 | 25.048 | 23.077 | 21.291 | 18.477 | 19.034 | 19.483 | 23.209 | 25.572 | 25.375 | 24.794 | 20.448 |
| General & Administrative Expenses
| 204.786 | 184.317 | 166.825 | 167.216 | 182.964 | 199.092 | 212.471 | 219.6 | 217.815 | 190.447 | 179.333 | 229.838 | 165.445 | 162.51 | 180.216 |
| Selling & Marketing Expenses
| 681.2 | 1,332.808 | 953.213 | 514.07 | 523.389 | 543.956 | 523.996 | 475.748 | 490.129 | 516.681 | 477.683 | 489.647 | 494.564 | 534.51 | 402.03 |
| SG&A
| 873.345 | 1,517.125 | 1,120.038 | 681.286 | 706.353 | 743.048 | 736.467 | 695.348 | 707.944 | 707.128 | 657.016 | 719.485 | 660.009 | 697.02 | 582.246 |
| Other Expenses
| 103.5 | 280.654 | 48.494 | -8.364 | 60.796 | 99.733 | 13.241 | -8.491 | 20.851 | 109.035 | 211.217 | 32.885 | 43.073 | 31.414 | 50.508 |
| Operating Expenses
| 889.177 | 1,532.437 | 1,138.584 | 701.809 | 731.401 | 766.125 | 757.758 | 713.825 | 726.978 | 726.611 | 680.225 | 745.057 | 685.384 | 721.814 | 602.694 |
| Operating Income
| -464.397 | 553.44 | 2,412.607 | 2,502.992 | 609.295 | 386.601 | 726.786 | 244.319 | 164.671 | -535.174 | 72.071 | -32.178 | 359.718 | 604.207 | 601.071 |
| Operating Income Ratio
| -0.031 | 0.031 | 0.116 | 0.162 | 0.034 | 0.018 | 0.037 | 0.015 | 0.01 | -0.026 | 0.003 | -0.002 | 0.02 | 0.033 | 0.043 |
| Total Other Income Expenses Net
| 128.74 | -9.066 | -5.163 | -21.003 | -51.091 | -55.349 | -48.934 | -47 | -70.206 | -103.036 | -57.197 | -38.015 | -27.869 | -34.982 | 46.462 |
| Income Before Tax
| -335.657 | 544.374 | 2,407.444 | 2,481.989 | 558.204 | 331.252 | 677.852 | 197.319 | 94.465 | -638.21 | 14.874 | -70.193 | 331.849 | 569.225 | 647.533 |
| Income Before Tax Ratio
| -0.022 | 0.03 | 0.116 | 0.16 | 0.032 | 0.015 | 0.034 | 0.012 | 0.006 | -0.03 | 0.001 | -0.004 | 0.018 | 0.031 | 0.046 |
| Income Tax Expense
| -72.475 | 132.296 | 557.512 | 562.171 | 160.227 | 123.279 | 175.773 | 76.442 | 26.94 | -7.024 | -2.509 | -6.446 | 60.817 | 42.988 | 111.02 |
| Net Income
| -273.537 | 412.078 | 1,849.932 | 1,919.818 | 397.977 | 207.973 | 502.079 | 120.877 | 67.525 | -631.186 | 17.383 | -63.747 | 271.032 | 526.237 | 536.513 |
| Net Income Ratio
| -0.018 | 0.023 | 0.089 | 0.124 | 0.023 | 0.01 | 0.025 | 0.007 | 0.004 | -0.03 | 0.001 | -0.003 | 0.015 | 0.029 | 0.038 |
| EPS
| -0.69 | 1.04 | 4.65 | 4.83 | 1 | 0.52 | 1.26 | 0.3 | 0.17 | -1.59 | 0.041 | -0.16 | 0.68 | 1.33 | 1.35 |
| EPS Diluted
| -0.69 | 1.04 | 4.64 | 4.82 | 1 | 0.52 | 1.26 | 0.3 | 0.17 | -1.59 | 0.041 | -0.16 | 0.68 | 1.32 | 1.35 |
| EBITDA
| -248.99 | 762.068 | 2,614.108 | 2,708.791 | 819.292 | 585.616 | 912.721 | 437.909 | 386.643 | -316.401 | 242.713 | 143.578 | 547.694 | 840.86 | 884.398 |
| EBITDA Ratio
| -0.016 | 0.042 | 0.126 | 0.175 | 0.046 | 0.027 | 0.046 | 0.027 | 0.023 | -0.015 | 0.011 | 0.008 | 0.03 | 0.046 | 0.063 |